ADVERTISEMENT
Videos
Understanding Indications, Tailoring Therapy Options for CLL Patients
05/18/2020
Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment for patients with CLL.
Advertisement
Advertisement
Advertisement
Current Issue
September 2024
Volume 21
Issue 3
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter